Recombinant Feline leukemia virus Envelope glycoprotein (env)[Envelope glycoprotein (env)]
-
Catalog numberMBS1259177
-
PricePlease ask
-
Size0.2 mg (E-Coli)
-
-
Products_typeRecombinant Protein
-
Products_gene_name[env]
-
SourceRecombinants or rec. proteins
-
Grouprecombinants
-
Gene target
-
Short nameRecombinant Feline leukemia virus Envelope glycoprotein (env)[Envelope glycoprotein (env)]
-
TechniqueRecombinant, Feline, felines, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. MyBioSource advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
-
HostE Coli or Yeast or Baculovirus or Mammalian Cell
-
SpeciesVirus, Sometimes til 5% of an area felines have specific IgGs for the feline retroviral feLV infecting Felidae. Also distemper and leukemia virusses apear in cats and have their specific IgG antibodies that are very stable. All cats used for producing immunoglobulins are screened and tested virus negative. Cat seras have usually higher IgG tirters than dog serum. Feline range = 10 to 20 mg/ml IgGs. Viruses
-
Alternative nameRec. Feline leukemia virus Envelope glycoprotein (env)[Envelope glycoprotein (env)]
-
Alternative techniquerec, cats
-
Virusleukemia
-
MeSH Data
-
Name
-
ConceptScope note: Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues.
-
Tree numbers
- C04.557.337.372
- C04.619.531
- E05.598.500.496.500
-
Qualifiersdiagnosis, parasitology, immunology, microbiology, diagnostic imaging, physiopathology, rehabilitation, enzymology, etiology, mortality, epidemiology, blood, cerebrospinal fluid, chemically induced, congenital, diet therapy, drug therapy, therapy, psychology, urine, virology, history, classification, economics, embryology, genetics, nursing, radiotherapy, ethnology, prevention & control, pathology, metabolism, complications, surgery